Beam Therapeutics logo

Beam Therapeutics

A synthetic biology company using CRISPR to develop a portfolio of genetic medicines.

5

Funding Rounds

$689.0m

Money raised

Overview

A synthetic biology company using CRISPR to develop a portfolio of genetic medicines.

Funding

Funding series

Funding Series Analysis

The company Beam Therapeutics has raised a total of $554m in funding over 5 rounds.

Key Insights:

  • Beam Therapeutics Venture round, January 19, 2021: $260m
  • Beam Therapeutics Venture round, February 11, 2020: $207m
  • Beam Therapeutics Series A round, May 2018: $87m
  • Beam Therapeutics Inc. funding round, March 2019: $135m
Beam Therapeutics logo
Beam Therapeutics Venture round, January 19, 2021 $260m
Beam Therapeutics logo
Beam Therapeutics Venture round, February 11, 2020 $207m
Beam Therapeutics logo
Beam Therapeutics Series A round, May 2018 $87m
Beam Therapeutics logo
Beam Therapeutics Inc. funding round, March 2019 $135m